Tag: AMR
Indian researchers develop new AI framework to aid discovery of next-generation...
New AI framework mimics real-world chemical synthesis to generate drug candidates that are both novel and lab-ready, offering faster routes to cancer and antibiotic resistance therapies
CIDSCON 2025: Judicious use of antibiotics essential to fight AMR: Experts
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
C-CAMP and UK’s Global AMR Innovation Fund announces new research call
The initiative focuses on delivering contextual solutions for low- and middle-income countries (LMICs) that are globally relevant and scalable
Fighting back against superbugs- A joint initiative by UK and India...
Researchers in the UK and India are collaborating to tackle the urgent issue of antibiotic overprescription by dentists
Cipla becomes first to launch AMR drug ‘ZEMDRI’ in India
Plazomicin is a novel anti-microbial with demonstrated activity against multi-drug resistant (MDR) bacteria and clinical efficacy in complicated Urinary Tract infections (cUTI)
AMR Challenge 2024-25, in collaboration with GAMRIF, announces 9 winners
The C-CAMP national AMR Challenge that was launched in Aug, 2024 received about 200 applications from innovators and startups across India
DBT partners Oxford Nanopore to launch two Genomic Centres of Excellence...
Institutes under the Department of BioTechnology (DBT) sign Letters of Intent with Oxford Nanopore to establish next-generation Genomic Centres of Excellence and new suite of R&D collaborations including in rare disease, newborn screening, oral cancer, and antimicrobial resistance (AMR) studies
In a first globally, Indian Medical Association launches “IMA AMR Smart...
This innovative program aims to combat the rising threat of Antimicrobial Resistance by implementing advanced Antimicrobial Stewardship & Infection Prevention & Control strategies in healthcare facilities across India
Facing the Silent Threat: How AMR Imperils Our Future
Antimicrobial resistance poses a silent yet formidable threat to global health, economic stability, and societal well-being, writes Dr Prabhu Vinayagam
CAHO & Orchid Pharma strategic partnership kicks off with a national...
Beyond the conference, Consortium of Accredited Healthcare Organizations (CAHO) and Orchid aim to strengthen hospital capacities to address AMR in tier 1 and tier 2 cities and hospitals, working with CAHO member hospitals